Nitromethaqualone
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 2-methyl-3-(2-methoxy-4-nitrophenyl)-4(3H)-quinazolinone | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 340-52-3 |
| ATC code | None |
| PubChem | CID 63339 |
| ChemSpider | 57006 |
| Chemical data | |
| Formula | C16H13N3O4 |
| Mol. mass | 311.29 |
| SMILES | eMolecules & PubChem |
Nitromethaqualone (Pamox)[1] is an analogue of methaqualone which has similar sedative and hypnotic properties.[2] It is significantly more potent (10x) compared to the parent compound; the typical dose is approximately 25 mg.[3] However the aromatic nitro group is metabolised to the corresponding aniline which proved to be a mutagen,[4][5] and consequently nitromethaqualone was not developed further due to toxicity concerns.
[edit] References
- ^ Patent US 3162634
- ^ Szirmai, A. (1963). "Pharmacological and Therapeutic Studies with a New Quinazolone Derivative, Nitromethaqualone". Therapeutische Umschau. Revue therapeutique 20: 542–546. PMID 14101319.
- ^ Van Boven, M.; Daenens, P. (1982). "Biotransformation and excretion of nitromethaqualone in rats and humans". Journal of pharmaceutical sciences 71 (10): 1152–1157. doi:10.1002/jps.2600711019. PMID 7143214.
- ^ J Pharm Sci 1982, 71(10), p.1152
- ^ Annales des Falsifications de l'Expertise Chimique et Toxicologique 1987, 80(854), p.25
 |
This sedative-related article is a stub. You can help Wikipedia by expanding it. |
